文献速递帕金森病与运动障碍认知障碍与痴呆神经肌肉病

SERAC1突变导致的进行性耳聋-肌张力障碍:67例研究

Progressive deafness-dystonia due to SERAC1 mutations: A study of 67 cases.
PubMed 文献 · Ann Neurol · 2017-01-01

这项多中心研究纳入59个家系67例SERAC1双等位基因变异者,中位年龄9岁,发现除2个轻型家系外表型高度一致:新生儿期严重可逆性肝功能障碍和低血糖见于>40%病例,6个月起肌张力低下(91%),继而痉挛(82%)和肌张力障碍(82%),68%从未行走,88%有显著智力障碍,98%有双侧基底节受累,98%尿3-甲基戊二酸升高。结论:MEGDHEL综合征是进行性耳聋-肌张力障碍综合征,常伴可逆性新生儿肝受累,病程高度一致。

要点

  • SERAC1双等位基因变异致MEGDHEL综合征,表型高度一致。
  • 新生儿期严重可逆性肝功能障碍和低血糖见于>40%病例。
  • 98%有双侧基底节受累,53%见特征性「壳核眼」征。

核心结论

  • MEGDHEL综合征是进行性耳聋-肌张力障碍综合征,常伴可逆性新生儿肝受累,病程高度一致。

研究设计与样本

  • 多中心研究纳入59个家系67例SERAC1双等位基因变异者(39例既往未报告),年龄范围5天至33.4岁,中位年龄9岁。

主要发现

  • 鉴定出41种不同SERAC1变异,其中20种既往未报告。
  • 除2个轻型表型家系外,所有受累个体表型和时程高度一致。
  • >40%病例见严重可逆性新生儿肝功能障碍和低血糖。
  • 中位6个月起肌张力低下(91%),中位15个月起痉挛(82%),中位18个月起肌张力障碍(82%)。

关键数值与推荐

  • MRI示双侧基底节受累98%,特征性「壳核眼」征53%。
  • 尿3-甲基戊二酸升高几乎见于所有患者(98%)。
  • 支持治疗聚焦痉挛和流涎,对接受治疗者有效;助听器或人工耳蜗未改善沟通能力。

临床怎么用

  • 对进行性耳聋-肌张力障碍伴新生儿肝受累者应检测SERAC1变异和尿3-甲基戊二酸。
  • 管理以痉挛和流涎的支持治疗为主,助听器或人工耳蜗对沟通改善有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: 3-Methylglutaconic aciduria, dystonia-deafness, hepatopathy, encephalopathy, Leigh-like syndrome (MEGDHEL) syndrome is caused by biallelic variants in SERAC1. METHODS: This multicenter study addressed the course of disease for each organ system. Metabolic, neuroradiological, and genetic findings are reported. RESULTS: Sixty-seven individuals (39 previously unreported) from 59 families were included (age range = 5 days-33.4 years, median age = 9 years). A total of 41 different SERAC1 variants were identified, including 20 that have not been reported before. With the exception of 2 families with a milder phenotype, all affected individuals showed a strikingly homogeneous phenotype and time course. Severe, reversible neonatal liver dysfunction and hypoglycemia were seen in >40% of all cases. Starting at a median age of 6 months, muscular hypotonia (91%) was seen, followed by progressive spasticity (82%, median onset = 15 months) and dystonia (82%, 18 months). The majority of affected individuals never learned to walk (68%). Seventy-nine percent suffered hearing loss, 58% never learned to speak, and nearly all had significant intellectual disability (88%). Magnetic resonance imaging features were accordingly homogenous, with bilateral basal ganglia involvement (98%); the characteristic "putaminal eye" was seen in 53%. The urinary marker 3-methylglutaconic aciduria was present in virtually all patients (98%). Supportive treatment focused on spasticity and drooling, and was effective in the individuals treated; hearing aids or cochlear implants did not improve communication skills. INTERPRETATION: MEGDHEL syndrome is a progressive deafness-dystonia syndrome with frequent and reversible neonatal liver involvement and a strikingly homogenous course of disease. Ann Neurol 2017;82:1004-1015.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Maas RR, Iwanicka-Pronicka K, Kalkan Ucar S, et al. Progressive deafness-dystonia due to SERAC1 mutations: A study of 67 cases. Ann Neurol. 2017. PMID: 29205472. doi:10.1002/ana.25110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。